We derived immune topographies for CD8 and CD163 from cell counts in the outer invasive margin and the tumor core for N = 287 patients using the median cell densities from the pan-cancer cohort as cutoff values (Figure 7A and B). The gene discussed is CD163; the disease is neoplasm.